2025 MLS Washington DC | Exon 20 (HER2 ad EGFR): Evolving Options

2025 MLS Washington DC | Exon 20 (HER2 ad EGFR): Evolving Options

Overview

NA

Target Audience

Physicians
Nurses
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Vamsi Velcheti, MD

Date of Release

October 4th, 2025